Search clinical trials for: ALS-008176

Total 254431 results

University of Wisconsin, Madison

Completed

The Utility of Pretracheal Stethoscope in Detecting Respiratory Abnormalities in Sedated Children

Sedation

United States
Acibadem University

Unknown

Ankaferd Blood Stopper for Hemostasis After Transradial Coronary Angiography

Hematoma | Radial Artery Injury | Bleed

Turkey
EMD Serono

Completed

ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency

Healthy
Argos Therapeutics

Completed

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

HIV Infections

Canada, United States
Samsung Medical Center

Completed

A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy

c-MET Positive Gastric Cancer

Korea, Republic of
University of Minnesota
Juvenile Diabetes Research Foundation

Completed

hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

Hypoglycemia | Type 1 Diabetes

United States
ROX Medical, Inc.

Completed

A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension

Hypertension

Belgium
Peking University Third Hospital

Completed

Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

China
AngioLab, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Nonalcoholic Steatohepatitis

Korea, Republic of
Alnylam Pharmaceuticals

Active, not recruiting

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1)

Hypertension

United States, Canada, United Kingdom, Puerto Rico, Ukraine
Masonic Cancer Center, University of Minnesota

Completed

QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

Acute Myeloid Leukemia

United States
2C Tech Corp

Completed

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Retinitis Pigmentosa

Mexico
Karolinska University Hospital

Completed

Early Postoperative Extracorporal Liver Support Therapy (ELS) as a Tool to Manage Post Hepatectomy Liver Failure (PLF)

Post Hepatectomy Liver Failure

Sweden
Synvista Therapeutics, Inc
Juvenile Diabetes Research Foundation

Terminated

Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria

Diabetes Mellitus, Type 1 | Diabetic Nephropathy

Australia, Denmark
Northwestern University

Enrolling by invitation

Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution

Epidermolysis Bullosa

United States
SBI Pharmaceuticals Co, Ltd.

Completed

Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes

Diabetes Mellitus, Type 2
Dr. Grant Pierce

Completed

Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease (FLAXPAD)

Peripheral Arterial Disease
Albany Molecular Research, Inc.
Westat

Terminated

A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors

Cancer

United States
Naestved Hospital

Recruiting

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Non-small Cell Lung Cancer | Malignant Pleural Effusion

Denmark
Alnylam Pharmaceuticals

Completed

A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation

Polyneuropathy | Hereditary Transthyretin-mediated (ATTRv) Amyloidosis

United States
Alteogen, Inc.

Completed

Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients

HER2-positive Breast Cancer

Korea, Republic of
Janssen Research & Development, LLC

Completed

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

Neoplasms | Colorectal Cancer | Advanced Solid Tumors | Non-small Cell Lung Cancer

France, United States
British Columbia Cancer Agency
Insight Genetics

Completed

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients (PCRTALK)

Nonsmall Cell Lung Cancer

Canada
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France; Fondation de l'Avenir; Fondation de France; ALN Implants...

Completed

PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption (PREPIC2)

Venous Thrombosis | Pulmonary Embolism

France
University of Toronto

Unknown

ALA and Prostate Cancer

Atrial Fibrillation | Prostate Cancer | Diet Therapy
University of Miami
Ikeno Clinic

Completed

5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Pomeranian Medical University Szczecin

Unknown

Biological Treatment of Amyotrophic Lateral Sclerosis (NeuStem-ALS)

Amyotrophic Lateral Sclerosis

Poland
Alzheon Inc.
Quotient Clinical

Completed

Single Dose Study of ALZ-801 Prototype Tablets

Alzheimer Disease
Royal College of Surgeons in Ireland - Medical...
Bahrain Defence Force Hospital

Withdrawn

Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19

Covid19 | SARS-COV 2
Conde, Bebiana, M.D.

Completed

Amyotrophic Lateral Sclerosis: a New Paradigm (ALSParadigm)

Amyotrophic Lateral Sclerosis

Portugal
Royal College of Surgeons in Ireland - Medical...
Bahrain Defence Force Hospital; Salmaniya Medical Complex

Completed

Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19

COVID-19 | SARS-CoV 2

Bahrain
Cynthia Harris
SurgiQuest, Inc.

Completed

Pneumoperitoneum Management With SurgiQuest AirSeal at Low vs. Higher Pressure ( PRESSURE ) (PRESSURE)

Shoulder Pain

United States
Altor BioScience
National Cancer Institute (NCI)

Terminated

QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

United States
Alnylam Pharmaceuticals

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGT

France, United Kingdom, Netherlands, Israel, Germany
Groupe Hospitalier Paris Saint Joseph
Hospital Avicenne

Completed

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

Enterobacterial Infection

France
Axsome Therapeutics, Inc.

Unknown

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions (COAST-1)

Osteoarthritis, Knee

United States, Australia
DUSA Pharmaceuticals, Inc.

Completed

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Actinic Keratosis

United States
Northwestern University

Completed

Genetics of Familial and Sporadic ALS (ALS)

Amyotrophic Lateral Sclerosis (ALS) | Lou Gehrig's Disease | Primary Lateral Sclerosis (PLS) | Familial Amyotrophic Lateral Sclerosis | ALS With Frontotemporal Dementia (ALS/FTD) | Motor Neuron Disease (MND) | Sporadic ALS (SALS)

United States
Mirati Therapeutics Inc.

Approved for marketing

Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation

Metastatic Cancer | Advanced Cancer | Malignant Neoplasm

United States
Alnylam Pharmaceuticals

Completed

Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus Infections

United States, Australia
Cynthia L Gay, MD
National Institute of Allergy and Infectious Diseases (NIAID); Argos Therapeutics

Completed

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

HIV

United States
Altor BioScience
National Cancer Institute (NCI)

Completed

QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
NX Development Corp

Active, not recruiting

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma (MEN-301)

Meningioma

United States, Austria, Germany
Elsan

Completed

WALANT Procedure in Carpal Tunnel Release

Anesthesia, Local | Carpal Tunnel | Median Nerve Neuralgia

France
Constantinos Hadjipanayis
National Cancer Institute (NCI); NX PharmaGen

Withdrawn

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Glioblastoma | Brain Cancer | Brain Tumors | Brain Tumor, Recurrent | Benign Neoplasms, Brain | Brain Neoplasms, Benign | Brain Neoplasms, Malignant | Brain Tumor, Primary | Intracranial Neoplasms | Neoplasms, Brain | Neoplasms, Intracranial | Primary Brain Neoplasms | Primary Malignant Brain Neoplasms | Primary Malignant... and other conditions

United States
Alnylam Pharmaceuticals

Recruiting

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) (KARDIA-3)

Hypertension | High Cardiovascular Risk

United States
Northwestern University

Not yet recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

Cutaneous T Cell Lymphoma

United States
Shanghai Dermatology Hospital
Peking University First Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaborators

Recruiting

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

Actinic Keratoses

China
Alnylam Pharmaceuticals

Terminated

A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease

Antitrypsin Deficiency Liver Disease

United Kingdom
Unity Health Toronto

Unknown

ALA on Glycemic Control in T2DM Participants

Type 2 Diabetes Mellitus

Search clinical trials for: ALS-008176

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations